Skip to search formSkip to main contentSkip to account menu

K-111

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
This article is part of Ahmed M. Khalid's PhD thesis, which is available in Munin: http://hdl.handle.net/10037/1802 
Review
2007
Review
2007
Kozva Co Ltd, under license from Roche Holding AG, is developing K-111, an orally available peroxisome proliferator-activated… 
Review
2006
Review
2006
Introduction: Prevalence of the metabolic syndrome has increased dramatically in recent years. Optimal patient care demands a… 
2002
2002
This study was undertaken to investigate the hypocholesterolemic activity ofBifidobacteria (B. breve K-110,B. breve K-111, andB… 
2001
2001
Panax ginseng is widely used as a Chinese medicine, but it takes a long time to reach harvest and to establish its qualified… 
2000
2000
The antitumor activity ofBifidobacterium breve K-110, and K-111, andB. infantis K-525 was investigated. TheseBifidobacterial… 
1999
1999
Antidiarrheal, anticostive and antimutagenic effects of Bifidobacterium breve K-110, K-111 and B. infantis K-525 isolated from… 
1999
1999
The protective effect of Bifidobacterium breve K-110, K-111 and B. infantis K-525 on carbon tetrachloride induced hepatotoxicity… 
1999
1999
저자 등이 건강한 한국사람으로부터 장내유해효소를 억제할 수 있은 장내환경개선효과가 우수한 한국형 유산균을 분리하여 소장수송능 효과, castor oil…